FORT LAUDERDALE, Fla. ( TheStreet) -- Home Diagnostics ( HDIX) has reached an agreement to be acquired for $11.50 a share, a premium of 90% to its closing stock price on Tuesday, by Japan's Nipro.

The total purchase price is $215 million. Home Diagnostics share closed Tuesday at $6.05.

The boards of both companies have approved the deal.

Shareholders owning about 15% of Home Diagnostics' have agreed to tender their shares to the Nipro offer, Home Diagnostics said in a press statement Wednesday.

Home Diagnostics is a maker of diabetes testing supplies. Nipro makes medical devices, drug products and medical and glass products.

The tender offer is expected to begin next week.

-- Reported by Joseph Woelfel in New York.

Follow TheStreet.com on Twitter and become a fan on Facebook.

More from Stocks

Dow Fluctuates, Nasdaq Strikes Record High

Dow Fluctuates, Nasdaq Strikes Record High

GE's Exit From Dow Could Be a Blessing in Disguise, Goldman Says

GE's Exit From Dow Could Be a Blessing in Disguise, Goldman Says

Own Retail Stocks? This Chart Will Make You Want to Instantly Cash Out

Own Retail Stocks? This Chart Will Make You Want to Instantly Cash Out

Disney CEO Bob Iger Touts Benefits of His Firm's Deal for Fox Beyond Just Money

Disney CEO Bob Iger Touts Benefits of His Firm's Deal for Fox Beyond Just Money

2 Things Fed Chairman Jerome Powell Just Said Upset Investors

2 Things Fed Chairman Jerome Powell Just Said Upset Investors